Related Experiment Videos
Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern
C Cordonnier1, E Escudier, F Verra
1Unit of Bone Marrow Transplantation, Hôpital Henri Mondor, Creteil, France.
The European Respiratory Journal
|January 1, 1994
Summary
Pulmonary endoscopic procedures are valuable for diagnosing pneumonia in neutropenic patients. However, neutropenia may decrease alveolar cell counts, potentially impacting lung cell populations.
Area of Science:
- Pulmonary Medicine
- Hematology
- Infectious Diseases
Background:
- Limited data exist on alveolar and blood cell populations during neutropenia.
- Neutropenia, defined as a polymorphonuclear (PMN) count ≤ 1,000.mm⁻³, affects immune response.
- Pneumonia investigations in hematologic malignancies often involve immunocompromised patients.
Purpose of the Study:
- To compare the diagnostic value of pulmonary endoscopic procedures in neutropenic versus non-neutropenic patients with pneumonia.
- To analyze the etiological patterns and cellularity of bronchoalveolar lavage (BAL) fluid in these groups.
Main Methods:
- Retrospective review of 118 pneumonia investigations in patients with hematologic malignancies.
- Bronchoalveolar lavage (BAL) was performed on all patients, with some undergoing additional protected specimen sampling.
- BAL specimens were analyzed cytologically and via bacteriological cultures for pathogens and opportunistic infections.
Main Results:
- The diagnostic yield of endoscopic procedures was 53% in neutropenic patients and 61% in non-neutropenic patients.
- Pneumonia etiology was similar, with more alveolar proteinosis in neutropenic patients and cytomegalovirus (CMV) in non-neutropenic patients.
- Absolute numbers of alveolar cells (macrophages, lymphocytes, PMNs) were significantly lower in neutropenic patients.
Conclusions:
- Neutropenic patients with pneumonia warrant the same investigative approach as non-neutropenic patients.
- Profound neutropenia may lead to decreased alveolar cellularity, possibly due to marrow aplasia or chemotherapy effects.
- Understanding these cellular changes is crucial for managing pulmonary infections in neutropenic individuals.